These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 13175379)

  • 1. [Procedures for the titration of vaccine lymph. I sensitivity of different parts of rabbit skin].
    ISHIKAWA T
    Kitasato Arch Exp Med; 1953 Sep; 26(1):67-73. PubMed ID: 13175379
    [No Abstract]   [Full Text] [Related]  

  • 2. Prediction of residual immunity to smallpox, by means of an intradermal skin test with inactivated vaccinia virus.
    Kim SH; Bang JW; Park KH; Park WB; Kim HB; Kim NJ; Jee Y; Cho H; Oh MD; Choe KW
    J Infect Dis; 2006 Aug; 194(3):377-84. PubMed ID: 16826487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proposed potency testing of smallpox vaccine. II. Comparative titration in rabbits, chick embryos and tissue culture.
    CABASSO VJ; MOORE IF; STEBBINS MR
    J Immunol; 1961 Jul; 87():46-8. PubMed ID: 13689641
    [No Abstract]   [Full Text] [Related]  

  • 4. Smallpox Vaccine Injury Compensation Program: administrative implementation. Interim final rule.
    Health Resources and Services Administration, HHS
    Fed Regist; 2003 Dec; 68(241):70079-106. PubMed ID: 14677536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An update on smallpox vaccine candidates and their role in bioterrorism related vaccination strategies.
    Wiser I; Balicer RD; Cohen D
    Vaccine; 2007 Jan; 25(6):976-84. PubMed ID: 17074424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aging of skin. I. Titration curves of human epidermis in relation to age.
    JOSEPH NR; MOLIMARD R; BOURLIERE F
    Gerontologia; 1957; 1(1):18-40. PubMed ID: 13405202
    [No Abstract]   [Full Text] [Related]  

  • 7. Standardization of a neutralizing anti-vaccinia antibodies titration method: an essential step for titration of vaccinia immunoglobulins and smallpox vaccines evaluation.
    Leparc-Goffart I; Poirier B; Garin D; Tissier MH; Fuchs F; Crance JM
    J Clin Virol; 2005 Jan; 32(1):47-52. PubMed ID: 15572006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of immunity to vaccinia virus by using diluted inactivated vaccinia vaccine solution for skin testing.
    Somekh E; Smetana Z; Tanay A; Dalal I; Babai I; Mendelson E
    Vaccine; 2004 Dec; 23(3):321-4. PubMed ID: 15530675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation of a screening instrument to identify persons for exclusion from smallpox vaccination.
    Belongia EA; Naleway A; Kieke B; Qutaishat S; Casey C; Shay DK; Chen RT
    Clin Infect Dis; 2005 Feb; 40(4):620-3. PubMed ID: 15712089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The new ACAM2000 vaccine and other therapies to control orthopoxvirus outbreaks and bioterror attacks.
    Handley L; Buller RM; Frey SE; Bellone C; Parker S
    Expert Rev Vaccines; 2009 Jul; 8(7):841-50. PubMed ID: 19538111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative efficacy of modified vaccinia Ankara (MVA) as a potential replacement smallpox vaccine.
    Phelps AL; Gates AJ; Hillier M; Eastaugh L; Ulaeto DO
    Vaccine; 2007 Jan; 25(1):34-42. PubMed ID: 16950548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and immunogenicity of IMVAMUNE, a promising candidate as a third generation smallpox vaccine.
    Vollmar J; Arndtz N; Eckl KM; Thomsen T; Petzold B; Mateo L; Schlereth B; Handley A; King L; Hülsemann V; Tzatzaris M; Merkl K; Wulff N; Chaplin P
    Vaccine; 2006 Mar; 24(12):2065-70. PubMed ID: 16337719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modified vaccinia Ankara: potential as an alternative smallpox vaccine.
    McCurdy LH; Larkin BD; Martin JE; Graham BS
    Clin Infect Dis; 2004 Jun; 38(12):1749-53. PubMed ID: 15227622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Smallpox vaccine: contraindications, administration, and adverse reactions.
    Maurer DM; Harrington B; Lane JM
    Am Fam Physician; 2003 Sep; 68(5):889-96. PubMed ID: 13678138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. US Civilian Smallpox Preparedness and Response Program, 2003.
    Strikas RA; Neff LJ; Rotz L; Cono J; Knutson D; Henderson J; Orenstein WA
    Clin Infect Dis; 2008 Mar; 46 Suppl 3():S157-67. PubMed ID: 18284355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A process for sentinel case review to assess causal relationships between smallpox vaccination and adverse outcomes, 2003-2004.
    Chapman LE; Iskander JK; Chen RT; Neff J; Birkhead GS; Poland G; Gray GC; Siegel J; Sepkowitz K; Robertson RM; Yancy C; Guerra FA; Gardner P; Modlin JF; Maurer T; Berger T; Flanders WD; Shope R
    Clin Infect Dis; 2008 Mar; 46 Suppl 3():S271-93. PubMed ID: 18284368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Society for assisted reproductive technology position statement on donor suitability of recipients of smallpox vaccine (vaccinia virus).
    Practice Committee of the American Society for Reproductive Medicine and the Society for Assisted Reproductive Technology
    Fertil Steril; 2004 Sep; 82 Suppl 1():S68-9. PubMed ID: 15363697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modeling a safer smallpox vaccination regimen, for human immunodeficiency virus type 1-infected patients, in immunocompromised macaques.
    Edghill-Smith Y; Venzon D; Karpova T; McNally J; Nacsa J; Tsai WP; Tryniszewska E; Moniuszko M; Manischewitz J; King LR; Snodgrass SJ; Parrish J; Markham P; Sowers M; Martin D; Lewis MG; Berzofsky JA; Belyakov IM; Moss B; Tartaglia J; Bray M; Hirsch V; Golding H; Franchini G
    J Infect Dis; 2003 Oct; 188(8):1181-91. PubMed ID: 14551889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short- and long-term immunogenicity and protection induced by non-replicating smallpox vaccine candidates in mice and comparison with the traditional 1st generation vaccine.
    Ferrier-Rembert A; Drillien R; Tournier JN; Garin D; Crance JM
    Vaccine; 2008 Mar; 26(14):1794-804. PubMed ID: 18336966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced immunogenicity and protective effect conferred by vaccination with combinations of modified vaccinia virus Ankara and licensed smallpox vaccine Dryvax in a mouse model.
    Meseda CA; Garcia AD; Kumar A; Mayer AE; Manischewitz J; King LR; Golding H; Merchlinsky M; Weir JP
    Virology; 2005 Sep; 339(2):164-75. PubMed ID: 15993917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.